134 related articles for article (PubMed ID: 30918878)
1. Prognostic factors for recurrence and survival in uterine leiomyosarcoma: Korean single center experience with 50 cases.
Paik ES; Kang JH; Kim J; Lee YJ; Choi CH; Kim TJ; Kim BG; Bae DS; Lee JW
Obstet Gynecol Sci; 2019 Mar; 62(2):103-111. PubMed ID: 30918878
[TBL] [Abstract][Full Text] [Related]
2. Uterine leiomyosarcoma: 14-year two-center experience of 31 cases.
Kim WY; Chang SJ; Chang KH; Yoon JH; Kim JH; Kim BG; Bae DS; Ryu HS
Cancer Res Treat; 2009 Mar; 41(1):24-8. PubMed ID: 19688068
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of preoperative ¹⁸F-FDG PET/CT in uterine leiomyosarcoma.
Park JY; Lee JW; Lee HJ; Lee JJ; Moon SH; Kang SY; Cheon GJ; Chung HH
J Gynecol Oncol; 2017 May; 28(3):e28. PubMed ID: 28382795
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors and impact of adjuvant chemotherapy for uterine leiomyosarcoma.
Wu TI; Chang TC; Hsueh S; Hsu KH; Chou HH; Huang HJ; Lai CH
Gynecol Oncol; 2006 Jan; 100(1):166-72. PubMed ID: 16182349
[TBL] [Abstract][Full Text] [Related]
5. Uterine Sarcoma: Clinical Presentation, Treatment and Survival Outcomes in Thailand.
Potikul C; Tangjitgamol S; Khunnarong J; Srijaipracharoen S; Thavaramara T; Pataradool K
Asian Pac J Cancer Prev; 2016; 17(4):1759-67. PubMed ID: 27221849
[TBL] [Abstract][Full Text] [Related]
6. Pelvic radiation improves local control after hysterectomy for uterine leiomyosarcoma: a 20-year experience.
Mahdavi A; Monk BJ; Ragazzo J; Hunter MI; Lentz SE; Vasilev SA; Tewari KS
Int J Gynecol Cancer; 2009 Aug; 19(6):1080-4. PubMed ID: 19820372
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors and survival in patients treated surgically for primary and recurrent uterine leiomyosarcoma: a single center experience.
Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
Anticancer Res; 2015 Apr; 35(4):2229-34. PubMed ID: 25862883
[TBL] [Abstract][Full Text] [Related]
8. How to deal with prognostic factors and radiotherapy results in uterine neoplasms with a sarcomatous component?
Rovirosa A; Ascaso C; Ordi J; Arenas M; Valduvieco I; Lejarcegui JA; Pahisa J; Torne A; Biete A
Clin Transl Oncol; 2009 Oct; 11(10):681-7. PubMed ID: 19828411
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors and survival in patients treated surgically for recurrent metastatic uterine leiomyosarcoma.
Hoang HL; Ensor K; Rosen G; Leon Pachter H; Raccuia JS
Int J Surg Oncol; 2014; 2014():919323. PubMed ID: 25045534
[TBL] [Abstract][Full Text] [Related]
10. The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma.
Park JY; Park SK; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2011 Aug; 122(2):255-9. PubMed ID: 21565389
[TBL] [Abstract][Full Text] [Related]
11. Does Lymphadenectomy Improve Survival in Uterine Leiomyosarcoma?
Tasci T; Karalok A; Taskin S; Ureyen I; Kımyon G; Tulek F; Ozfuttu A; Turan T; Tulunay G; Kose MF; Ortac F
Int J Gynecol Cancer; 2015 Jul; 25(6):1031-6. PubMed ID: 25853382
[TBL] [Abstract][Full Text] [Related]
12. Clinical Features and Prognostic Factors in Patients With Uterine Leiomyosarcoma: A Single-Center Experience.
Yalciner M; Bölek H; Berna Köksoy E
Cureus; 2023 Aug; 15(8):e43681. PubMed ID: 37724232
[TBL] [Abstract][Full Text] [Related]
13. Surgical resection of pulmonary and extrapulmonary recurrences of uterine leiomyosarcoma.
Leitao MM; Brennan MF; Hensley M; Sonoda Y; Hummer A; Bhaskaran D; Venkatraman E; Alektiar K; Barakat RR
Gynecol Oncol; 2002 Dec; 87(3):287-94. PubMed ID: 12468327
[TBL] [Abstract][Full Text] [Related]
14. Leiomyosarcoma of the uterus: a clinicopathologic study of 21 cases.
Hsieh CH; Lin H; Huang CC; Huang EY; Chang SY; ChangChien CC
Acta Obstet Gynecol Scand; 2003 Jan; 82(1):74-81. PubMed ID: 12580845
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome affected by tumor morcellation in unexpected early uterine leiomyosarcoma.
Lin KH; Torng PL; Tsai KH; Shih HJ; Chen CL
Taiwan J Obstet Gynecol; 2015 Apr; 54(2):172-7. PubMed ID: 25951723
[TBL] [Abstract][Full Text] [Related]
16. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors and treatment outcomes in 93 patients with uterine sarcoma from 4 centers in Turkey.
Durnali A; Tokluoğlu S; Özdemir N; Inanç M; Alkiş N; Zengin N; Sönmez ÖU; Küçüköner M;
Asian Pac J Cancer Prev; 2012; 13(5):1935-41. PubMed ID: 22901150
[TBL] [Abstract][Full Text] [Related]
18. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy.
Giuntoli RL; Metzinger DS; DiMarco CS; Cha SS; Sloan JA; Keeney GL; Gostout BS
Gynecol Oncol; 2003 Jun; 89(3):460-9. PubMed ID: 12798712
[TBL] [Abstract][Full Text] [Related]
19. Surgical cytoreduction in patients with metastatic uterine leiomyosarcoma at the time of initial diagnosis.
Leitao MM; Zivanovic O; Chi DS; Hensley ML; O'Cearbhaill R; Soslow RA; Barakat RR
Gynecol Oncol; 2012 May; 125(2):409-13. PubMed ID: 22366592
[TBL] [Abstract][Full Text] [Related]
20. Secondary cytoreductive surgery in recurrent uterine leiomyosarcoma: a multi-institutional study.
Bizzarri N; Ghirardi V; Di Fiore GLM; De Iaco P; Gadducci A; Casarin J; Perrone AM; Pasciuto T; Scambia G; Fagotti A
Int J Gynecol Cancer; 2019 Sep; 29(7):1134-1140. PubMed ID: 31420411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]